Press Release
February 2007
20/20 has Completed a Financing Round of $1.75 million and plans to use the funds to advance its blood test for the early detction of lung cancer. Participating in the round were over three dozen individual investors, including seven medical doctors and several investors from previous rounds. Each of these investors will receive a 50% refund or tax credit for their investment pursuant to Maryland's new Biotechnology Investor Tax Credit that became operational July 1, 2006. Out of state investors in 20/20 were able to claim a refund from Maryland in lieu of a tax credit. Maryland’s governor Martin O’Malley has budgeted $6 million for fiscal year 2007 to the successful Biotechnology Investment Tax Credit program thereby renewing the State’s commitment to this successful initiative. The company plans another round beginning in the second quarter of this year. For details please visit Maryland's Deptartment of Business and Economic Development website or call Jerry Troy from 20/20 at 240-453-6338.
|